University of Iowa spin-off Viewpoint Molecular Targeting has recently been awarded a $2 million Phase II NIH SBIR to support development of a new treatment for metastatic melanoma.
Learn more about Tammy Lowe, Clinical Trial & Data Management Research Associate in the Division of Endocrinology & Metabolism.
Congratulations to the research team of Philip Polgreen , Ted Herman , Manish Suneja , and Enrique Leira on receiving the University of Iowa Pilot Grant Program for Translational Stroke Studies award. The team is focusing their research on blood pressure and has prototyped a new platform...
ICTS Director Patricia Winokur, MD discusses the chikungunya vaccine and how the clinical trials are conducted on Iowa Public Radio's River to River.
Congratulations to May 2017 DAISY Award winner Jane Weber, BSN, RN, a nurse in the Clinical Research Unit. Weber, who cares for a group of boys in a Duchenne muscular dystrophy trial, plans special parties for children nearing completion of the drug trial. Weber “has truly made their time at...
The University of Iowa is one of three sites in the United States currently enrolling participants for an experimental chikungunya virus vaccine study. Our very own Patricia Winokur, MD, is the principal investigator for the trial.
Check out the Association for Clinical and Translation Science Newsletters for all translational science new, updates and more.
Elizabeth Chrischilles, a University of Iowa Professor of Epidemiology and Director of the Health Effectiveness Research Center, is currently leading breast cancer outcomes research studies with the Greater Plains Collaborative breast cancer survey.
The new “Distraction in Action” application developed at the University of Iowa helps children remain preoccupied while receiving a shot.
Research on a new drug to treat a rare form of muscular dystrophy was in-part conducted at the University of Iowa. The drug was recently approved by the Food and Drug Administration (FDA).